Checkpoint Therapeutics
NASDAQ: CKPT
Healthcare
Biotechnology
Rank
#16109
Market Cap
348.04 M
Volume
1.16 M
Price
4.16
Change (%)
0.12%
Country or region
United States
United States
Checkpoint Therapeutics's latest marketcap:
348.04 M
As of 05/21/2025, Checkpoint Therapeutics's market capitalization has reached $348.04 M. According to our data, Checkpoint Therapeutics is the 16109th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 348.04 M |
| Revenue (ttm) | 41,000 |
| Net Income (ttm) | -56,507,000 |
| Shares Out | 83.76 M |
| EPS (ttm) | -1.22 |
| Forward PE | 8.19 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/13/2025 |
Market Cap Chart
Data Updated: 05/21/2025
Checkpoint Therapeutics's yearly market capitalization.
Checkpoint Therapeutics has seen its market value grow from $179.89 M to $348.04 M since 2020, representing a total increase of 93.47% and an annual compound growth rate (CAGR) of 16.23%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/21/2025 | $348.04 M | 123.53% |
| 12/31/2024 | $156.26 M | 190.05% |
| 12/29/2023 | $53.87 M | 2.84% |
| 12/30/2022 | $52.39 M | -79.89% |
| 12/31/2021 | $260.53 M | 44.83% |
| 12/31/2020 | $179.89 M |
Company Profile
Frequently Asked Questions
As of 05/21/2025, Checkpoint Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $348.04 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Checkpoint Therapeutics global market capitalization ranking is approximately 16109 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2014 |
| IPO Date | 06/26/2017 |
| Employees | 24 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address | |
| Website |
